Northland Capmk Weighs in on Abacus Life Q1 Earnings

Abacus Life, Inc. (NASDAQ:ABL) – Equities research analysts at Northland Capmk issued their Q1 2025 earnings estimates for Abacus Life in a research report issued on Monday, November 25th. Northland Capmk analyst M. Grondahl anticipates that the company will post earnings of $0.15 per share for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.64 per share. Northland Capmk also issued estimates for Abacus Life’s Q2 2025 earnings at $0.18 EPS, Q3 2025 earnings at $0.21 EPS, Q4 2025 earnings at $0.24 EPS and FY2025 earnings at $0.78 EPS.

Abacus Life (NASDAQ:ABL) last issued its earnings results on Thursday, November 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.14 by $0.06. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The business had revenue of $28.15 million during the quarter, compared to analysts’ expectations of $26.08 million. During the same quarter last year, the firm posted $0.01 earnings per share.

ABL has been the topic of a number of other research reports. B. Riley Financial restated a “buy” rating and issued a $16.00 price objective on shares of Abacus Life in a report on Friday, August 30th. Northland Securities initiated coverage on shares of Abacus Life in a research note on Thursday, October 24th. They set an “outperform” rating and a $13.50 price target on the stock. TD Cowen assumed coverage on shares of Abacus Life in a research note on Wednesday, August 7th. They issued a “buy” rating and a $14.00 price objective for the company. B. Riley increased their target price on shares of Abacus Life from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 price target (up previously from $12.00) on shares of Abacus Life in a research report on Friday, November 8th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $14.70.

Abacus Life Trading Up 3.3 %

Shares of NASDAQ:ABL opened at $8.08 on Thursday. The firm has a fifty day moving average of $9.22 and a two-hundred day moving average of $9.75. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. Abacus Life has a 12-month low of $6.56 and a 12-month high of $13.25. The firm has a market capitalization of $603.17 million, a P/E ratio of -43.44 and a beta of 0.15.

Hedge Funds Weigh In On Abacus Life

A number of institutional investors and hedge funds have recently bought and sold shares of ABL. Richard W. Paul & Associates LLC boosted its holdings in Abacus Life by 4.8% in the 2nd quarter. Richard W. Paul & Associates LLC now owns 30,448 shares of the company’s stock valued at $263,000 after purchasing an additional 1,401 shares during the period. Allspring Global Investments Holdings LLC acquired a new position in shares of Abacus Life during the second quarter valued at about $9,909,000. Principal Financial Group Inc. bought a new stake in shares of Abacus Life in the second quarter valued at about $8,105,000. Stieven Capital Advisors L.P. acquired a new stake in Abacus Life during the second quarter worth about $2,811,000. Finally, Levin Capital Strategies L.P. bought a new position in Abacus Life during the second quarter valued at about $130,000.

Insider Activity at Abacus Life

In other Abacus Life news, Director Adam Samuel Gusky purchased 18,241 shares of the business’s stock in a transaction dated Friday, November 22nd. The stock was bought at an average cost of $7.54 per share, for a total transaction of $137,537.14. Following the completion of the acquisition, the director now directly owns 40,959 shares in the company, valued at $308,830.86. This represents a 80.29 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jay J. Jackson sold 2,031,250 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $8.00, for a total value of $16,250,000.00. Following the completion of the sale, the chief executive officer now directly owns 10,562,000 shares of the company’s stock, valued at $84,496,000. This represents a 16.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 79.20% of the stock is currently owned by company insiders.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.